Press releaseGlobe Newswire
Avalyn Pharma
AVLN · NASDAQ
$24.63+$1.30 (+5.57%)TodayMarket closed ·
Prev close $23.33
Latest news
- Press releaseGlobe Newswire
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- Press releaseGlobe Newswire
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
- Press releaseGlobe Newswire
Avalyn to Participate in the Jefferies Global Healthcare Conference
- Press releaseBusiness Wire
Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics' Acquisition by UCB
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.